Rare Disease Drug Sales to Exceed $400 Billion by 2032 The rare disease drug market is on track for remarkable...
By Web Desk | March 14, 2026 | Category: Business, Health, World
Patent Expirations Set Biopharma on a Tough Path for 2026 The biopharma industry is entering 2026 with uncertainty, as patent...
By Web Desk | March 14, 2026 | Category: Health, Opinion, World